ANIK
ANIK
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
3
$264K
Insider Sales
0
$0
Total Volume
$264K
6 transactions
Net Activity
+$264K
Net buying
Sentiment Rating
Strong AccumulationCEO Conviction Index
High Conviction Accumulation
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
- •Cluster buying: 3 unique insiders purchased shares, showing strong alignment.
- •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
P - Purchase Insiders
$823.57M total
Griffin Stephen D.
Pres, CEO
$150K total
Henneman John B III
Dir
$73K total
Fischetti Gary P
Dir
$41K total
Quick Actions
ANIK has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at ANIK (ANIK) engaged in a total of 6 transactions reported via SEC Form 4 filings. Among these, 3 were open-market purchases and 0 were sales. The total volume of insider trading reached $264K.
The net insider activity for ANIK shows a net buying bias of $264K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 36.2K shares valued at $441.19M on Apr 30, 2026.
(ANIK) Risk Channels and Responsive Allocation
Anika Therapeutics (ANIK) Beats Q3 Earnings and Revenue Estimates
ANIK - Anika Therapeutics Inc Stock Price and Quote
$ANIK stock is down 22% today. Here's what we see in our data.
Anika (ANIK) Is a Great Choice for 'Trend' Investors, Here's Why
Bullish On Anika Therapeutics’s Pullback As Integrity Scales (NASDAQ:ANIK)
FAQs About ANIK Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for ANIK.